Century Therapeutics boosts iPSC manufacturing space in New Jersey as part of company wide expansion
It’s been a busy few years for Pennsylvania-based Century Therapeutics since it burst onto the scene with a $250M funding haul in summer 2019. Now, the biotech is scaling up its manufacturing capacity as part of a companywide footprint buildout.
Century has leased 53,000 square feet of space in Branchburg, New Jersey, for a new manufacturing facility for its induced pluripotent stem cell therapies. That buildout is part of a larger expansion that will include expanded lab and corporate space in Philadelphia.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,900+ biopharma pros reading Endpoints daily — and it's free.